Skip to main content
. 2016 Aug 15;37(9):1229–1236. doi: 10.1038/aps.2016.73

Figure 4.

Figure 4

Salivary PAc-specific IgA and serum PAc-specific IgG antibody levels in rats immunized intranasally with pCIA-P in combination with pCCL17/VAX, pCCL19/VAX, pCCL17/VAX plus pCCL19/VAX, or pVAX1. Saliva and serum samples were collected 52 days after the first immunization. The specific anti-PAc salivary IgA (A) and specific anti-PAc serum IgG (B) concentrations were determined by ELISA. The data are expressed as the mean±SD. n=5. *P<0.05, **P<0.01 vs the pVAX1 group. ##P<0.01 vs the pCCL17/VAX1 group. $P<0.05 vs the pCCL19/VAX1 group.